Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Cerebral Arteriovenous Malformations With SQUID Liquid Embolic Agent - The CHOICE Study A Non-interventional, Prospective, Single-arm, International, Multicenter Study

NCT03413852 is registered in ClinicalTrials.gov with Embo-Flüssigkeiten A.G. as lead sponsor.

NCT NCT03413852
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03413852 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Cerebral Arteriovenous Malformations With SQUID Liquid Embolic Agent - The CHOICE Study A Non-interventional, Prospective, Single-arm, International, Multicenter Study
Lead sponsor
Embo-Flüssigkeiten A.G.
Phase
Observational
Overall status
Unknown status
Start date
May 11, 2018
Completion date
August 31, 2022
Enrollment
111 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral arteriovenous malformation